Terms: = Head and neck cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Prognosis
320 results:
1. prognosis of primary breast salivary gland-type carcinoma: a propensity score-matching analysis with invasive carcinoma of no special type based on the SEER database for years 2010-2020.
Ch'ng ES
Breast Cancer; 2024 May; 31(3):496-506. PubMed ID: 38546966
[TBL] [Abstract] [Full Text] [Related]
2. Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus.
Porschen R; Fischbach W; Gockel I; Hollerbach S; Hölscher A; Jansen PL; Miehlke S; Pech O; Stahl M; Vanhoefer U; Ebert MPA
United European Gastroenterol J; 2024 Apr; 12(3):399-411. PubMed ID: 38284661
[TBL] [Abstract] [Full Text] [Related]
3. Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.
Zhou J; Wei S; Guo X; Huang Y; Zhang Y; Hong Y; Chen X; Lu M; Zheng F; Zheng C
BMC Cancer; 2023 Dec; 23(1):1247. PubMed ID: 38110870
[TBL] [Abstract] [Full Text] [Related]
4. her2 low expression breast cancer subtyping and their correlation with prognosis and immune landscape based on the histone modification related genes.
Li J; Yao J; Qi L
Sci Rep; 2023 Dec; 13(1):21753. PubMed ID: 38066224
[TBL] [Abstract] [Full Text] [Related]
5. her2-targeted therapies for salivary gland cancers.
Filippini DM; Pagani R; Tober N; Lorini L; Riefolo M; Molinari G; Burato A; Alfieri S; Bossi P; Presutti L
Oral Oncol; 2024 Jan; 148():106612. PubMed ID: 38016228
[TBL] [Abstract] [Full Text] [Related]
6. Unveiling Therapeutic Targets for Esophageal cancer: A Comprehensive Review.
Acharya R; Mahapatra A; Verma HK; Bhaskar LVKS
Curr Oncol; 2023 Oct; 30(11):9542-9568. PubMed ID: 37999111
[TBL] [Abstract] [Full Text] [Related]
7. High PGAP3 expression is associated with lymph node metastasis and low CD8
Hao N; Li M; Wang J; Song Y; Zhao Y; Zhang L; Yang X; Chen L; Ma J; Jia Q; Sui F
Pathol Res Pract; 2023 Nov; 251():154890. PubMed ID: 37839361
[TBL] [Abstract] [Full Text] [Related]
8. Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus head and neck Carcinoma: A Phase 2 Randomized Clinical Trial.
Wong SJ; Torres-Saavedra PA; Saba NF; Shenouda G; Bumpous JM; Wallace RE; Chung CH; El-Naggar AK; Gwede CK; Burtness B; Tennant PA; Dunlap NE; Redman R; Stokes WA; Rudra S; Mell LK; Sacco AG; Spencer SA; Nabell L; Yao M; Cury FL; Mitchell DL; Jones CU; Firat S; Contessa JN; Galloway T; Currey A; Harris J; Curran WJ; Le QT
JAMA Oncol; 2023 Nov; 9(11):1565-1573. PubMed ID: 37768670
[TBL] [Abstract] [Full Text] [Related]
9. Molecular characterisation of tumours of the lacrimal apparatus.
Vibert R; Cyrta J; Girard E; Vacher S; Dupain C; Antonio S; Wong J; Baulande S; De Sousa JMF; Vincent-Salomon A; Masliah-Planchon J; Girard N; Le Tourneau C; Kamal M; Bièche I
Histopathology; 2023 Dec; 83(6):925-935. PubMed ID: 37706251
[TBL] [Abstract] [Full Text] [Related]
10. Clinically conserved genomic subtypes of gastric adenocarcinoma.
Jeong YS; Eun YG; Lee SH; Kang SH; Yim SY; Kim EH; Noh JK; Sohn BH; Woo SR; Kong M; Nam DH; Jang HJ; Lee HS; Song S; Oh SC; Lee J; Ajani JA; Lee JS
Mol Cancer; 2023 Sep; 22(1):147. PubMed ID: 37674200
[TBL] [Abstract] [Full Text] [Related]
11. Partial response to RC-48 as palliative treatment in a patient with locallocally advanced carcinoma ex pleomorphic adenoma harboring a her2 mutation: a case report.
Yu W; Ding C; Li K
Oral Oncol; 2023 Nov; 146():106541. PubMed ID: 37595449
[TBL] [Abstract] [Full Text] [Related]
12. CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database.
Kobayashi K; Saito Y; Kage H; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Jpn J Clin Oncol; 2023 Aug; 53(9):798-807. PubMed ID: 37357968
[TBL] [Abstract] [Full Text] [Related]
13. Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy - An Update.
Wöll E; Amann A; Eisterer W; Gerger A; Grünberger B; Rumpold H; Weiss L; Winder T; Greil R; Prager GW
Anticancer Res; 2023 Jul; 43(7):2889-2897. PubMed ID: 37351962
[TBL] [Abstract] [Full Text] [Related]
14. CircMAN1A2 promotes vasculogenic mimicry of nasopharyngeal carcinoma cells through upregulating erbb2 via sponging miR-940.
Mo H; Shen J; Zhong Y; Chen Z; Wu T; Lv Y; Xie Y; Hao Y
Oncol Res; 2022; 30(4):187-199. PubMed ID: 37304410
[TBL] [Abstract] [Full Text] [Related]
15. Therapeutic Advances in the Treatment of Gastroesophageal cancers.
Li JJ; Rogers JE; Yamashita K; Waters RE; Blum Murphy M; Ajani JA
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238666
[TBL] [Abstract] [Full Text] [Related]
16. Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival.
Takano EA; Younes MM; Meehan K; Spalding L; Yan M; Allan P; Fox SB; Redfern A; Clouston D; Giles GG; Christie EL; Anderson RL; Zethoven M; Phillips KA; Gorringe K; Britt KL
BMC Cancer; 2023 May; 23(1):459. PubMed ID: 37208678
[TBL] [Abstract] [Full Text] [Related]
17. [Salivary gland cancer: new therapeutic approaches].
Herrera Gomez RG; Mederos N; Szturz P; Degrauwe N; Jankovic J; Cristina V
Rev Med Suisse; 2023 May; 19(827):958-963. PubMed ID: 37195109
[TBL] [Abstract] [Full Text] [Related]
18. The Emerging Role of Circulating Tumor DNA in Non-Colorectal Gastrointestinal cancers.
Lee MS; Kaseb AO; Pant S
Clin Cancer Res; 2023 Sep; 29(17):3267-3274. PubMed ID: 37092904
[TBL] [Abstract] [Full Text] [Related]
19. Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth.
Jia X; Wang P; Huang C; Zhao D; Wu Q; Lu B; Nie W; Huang L; Tian X; Li P; Laster KV; Jiang Y; Li X; Li H; Dong Z; Liu K
J Exp Clin Cancer Res; 2023 Apr; 42(1):97. PubMed ID: 37088855
[TBL] [Abstract] [Full Text] [Related]
20. Esophageal and Esophagogastric Junction cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Ajani JA; D'Amico TA; Bentrem DJ; Cooke D; Corvera C; Das P; Enzinger PC; Enzler T; Farjah F; Gerdes H; Gibson M; Grierson P; Hofstetter WL; Ilson DH; Jalal S; Keswani RN; Kim S; Kleinberg LR; Klempner S; Lacy J; Licciardi F; Ly QP; Matkowskyj KA; McNamara M; Miller A; Mukherjee S; Mulcahy MF; Outlaw D; Perry KA; Pimiento J; Poultsides GA; Reznik S; Roses RE; Strong VE; Su S; Wang HL; Wiesner G; Willett CG; Yakoub D; Yoon H; McMillian NR; Pluchino LA
J Natl Compr Canc Netw; 2023 Apr; 21(4):393-422. PubMed ID: 37015332
[TBL] [Abstract] [Full Text] [Related]
[Next]
